Isoxsuprine-d6 (hydrochloride)
(Synonyms: 异舒普林盐酸盐 d6 (盐酸盐)) 目录号 : GC47471A neuropeptide with diverse biological activities
Cas No.:2706004-35-3
Sample solution is provided at 25 µL, 10mM.
Isoxsuprine-d6 is intended for use as an internal standard for the quantification of isoxsuprine by GC- or LC-MS. Isoxsuprine is an adrenergic receptor modulator that has α-adrenergic receptor (α-AR) antagonist and β-AR agonist properties.1,2 It induces vasodilation of isolated equine common digital artery strips precontracted with norepinephrine, indicating an α-AR effect, and induces relaxation of isolated fowl cecum, an effect that can be blocked by the β-AR antagonist propranolol .2,3 Isoxsuprine has antinociceptive effects in an acetic acid writhing test in mice.4 It also inhibits oxytocin-induced contractions in isolated rat uterus (IC50 = 9.15 µM).5 It delays labor onset in rats by 31.63 hours when administered at a dose of 10 mg/kg per day on days 13 to 21 of gestation but increases heart rate with increasing concentration.
1.Cook, P., and James, I.Cerebral vasodilators (second of two parts)N. Engl. J. Med.305(26)1560-1564(1981) 2.Belloli, C., Carcano, R., Arioli, F., et al.Affinity of isoxsuprine for adrenoreceptors in equine digital artery and implications for vasodilatory actionEquine Vet. J.32(2)119-124(2000) 3.Ekert, R.S., and Macallister, C.G.Isoxsuprine hydrochloride in the horse: A reviewJ. Vet. Pharmacol. Ther.25(2)81-87(2002) 4.Bentley, G.A., and Starr, J.The antinociceptive action of some β-adrenoceptor agonists in miceBr. J. Pharmacol.88(3)515-521(1988) 5.Viswanathan, C.L., Kodgule, M.M., and Chaudhari, A.S.Design, synthesis and evaluation of racemic 1-(4-hydroxyphenyl)-2-[3-(substituted phenoxy)-2-hydroxy-1-propyl]amino-1-propanol hydrochlorides as novel uterine relaxantsBioorg. Med. Chem. Lett.15(15)3532-3535(2005)
Cas No. | 2706004-35-3 | SDF | |
别名 | 异舒普林盐酸盐 d6 (盐酸盐) | ||
Canonical SMILES | OC1=CC=C(C(O)C(C)NC(C([2H])([2H])[2H])([2H])C([2H])([2H])OC2=CC=CC=C2)C=C1.Cl | ||
分子式 | C18H17D6NO3.HCl | 分子量 | 343.9 |
溶解度 | DMF: 10 mg/ml,DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml,DMSO: 5 mg/ml,Ethanol: 0.1 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.9078 mL | 14.5391 mL | 29.0782 mL |
5 mM | 0.5816 mL | 2.9078 mL | 5.8156 mL |
10 mM | 0.2908 mL | 1.4539 mL | 2.9078 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet